AMGN34:BVMF
Amgen
93,16 BRL
0,00%
(0,00) 1D
10. nov., 17:45:16 GMT -3 · BRL
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za AMGN34 …
Odpri
92,46 BRL
Visoka
93,16 BRL
Nizka
92,38 BRL
Tržna kapitalizacija
251,65 mrd.
Povprečni promet
318,00
Promet
6,00
52-tedenski najvišji tečaj
94,72 BRL
52-tedenski najnižji tečaj
47,76 BRL
Št. izdanih delnic
540,91 mio.
Št. zaposlenih
32 tis.
Odpri
92,46 BRL
Visoka
93,16 BRL
Nizka
92,38 BRL
Tržna kapitalizacija
251,65 mrd.
Povprečni promet
318,00
Promet
6,00
52-tedenski najvišji tečaj
94,72 BRL
52-tedenski najnižji tečaj
47,76 BRL
Št. izdanih delnic
540,91 mio.
Št. zaposlenih
32 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Yahoo Finance
·
pred 11 urami
Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?
Investing.com Canada
·
pred 1 dnevom
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
Amgen
·
pred 1 tednom
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
The Motley Fool
·
pred 1 tednom
Amgen Just Gave Its Shareholders Great News
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Vizitka: Amgen
Generalni direktorRobert A. Bradway
Št. zaposlenih31,5 tis.
Ustanovljeno1980
SedežThousand Oaks, Kalifornija, Združene države Amerike
SektorHealth Care
Panoga-
Spletno mestoamgen.com